In Malaysia’s evolving health care landscape, general practitioners (GPs) have long served as the backbone of primary care delivering essential, community-based medical services that form the first line of defence against illness.
However, in recent years, GPs have found themselves weighed down by an expanding web of regulations from multiple government agencies.
From licensing under the Private Healthcare Facilities and Services Act (PHFSA) to compliance with local council, Fire and Rescue Department, Department of Environment (DOE), and Department of Occupational Safety and Health (DOSH) requirements, the administrative burden continues to grow heavier.
At the same time, community pharmacies are increasingly offering clinical services such as blood testing, vaccination, and health screenings, but with far fewer regulatory checks.
This raises an important question: why are GPs subjected to stricter scrutiny than pharmacies providing similar health care services?
The Burden On General Practitioners
A typical GP clinic must navigate an intricate network of agencies and regulations:
- Ministry of Health (MOH): PHFSA licensing covering personnel, equipment, scope of services, and waste disposal.
- Local Council: Approvals for business premises, signage, parking, and zoning.
- Fire and Rescue Department: Fire safety and evacuation compliance.
- DOE: Proper disposal of clinical waste through approved contractors.
- DOSH: Occupational safety, especially where radiation, chemicals, or procedural equipment are used.
Each agency requires separate forms, inspections, fees, and documentation. Many of these requirements overlap or duplicate information already verified by the MOH.
Non-compliance even for minor technicalities can lead to warnings, fines, or suspension of operating licences.
For small, single-doctor clinics, these cumulative costs and bureaucratic hurdles can be overwhelming.
Pharmacies Expanding Into Clinical Roles
Meanwhile, community pharmacies have broadened their scope to include:
- On-site blood tests and health screenings.
- Vaccination services.
- Minor ailments management.
- Teleconsultations or prescription renewals.
Pharmacists undoubtedly play a vital and respected role in health care. Their accessibility and medication expertise are invaluable.
However, as pharmacies increasingly provide medical-type procedures, they step into areas traditionally regulated under the PHFSA, yet without equivalent regulatory oversight.
For instance, when a GP provides vaccinations, the clinic must:
- Maintain a cold-chain log for every vial.
- Submit vaccine stock records to the MOH.
- Store and dispose of sharps under DOE-approved conditions.
- Ensure a doctor is present for medical emergencies.
Are pharmacies performing these same services under the same standards and monitoring? The answer is not always clear.
Unequal Scrutiny, Unequal Standards
When a GP draws blood or administers an injection, every item, from syringes to swabs, must be accounted for and disposed of under environmental health regulations.
When a pharmacy performs a similar act, the same degree of scrutiny often does not occur.
This inconsistency creates an uneven regulatory playing field. It does not only burden one group of health care providers, but also raises potential safety and accountability gaps.
Public confidence depends on consistent standards, not on who provides the service.
The Need For A Level Playing Field
This is not an argument against pharmacy development or pharmacist-led services. APPS firmly supports collaborative care, where pharmacists, doctors, and allied health professionals work hand-in-hand to improve patient outcomes.
However, collaboration must rest on equitable and transparent regulation.
If pharmacies wish to offer clinical services, they should be held to the same public safety standards that apply to medical clinics, including environmental, operational, and procedural compliance.
Likewise, GPs should not be suffocated by outdated or redundant administrative layers that serve little purpose other than bureaucracy.
Policy Recommendations
The MOH should take leadership to:
- Streamline GP clinic regulatory processes consolidating oversight under a single coordinating body to reduce duplication.
- Clarify regulatory boundaries defining clearly what services pharmacies may perform and under what conditions.
- Ensure parity in enforcement similar services should attract similar oversight, regardless of provider type.
- Encourage interprofessional collaboration through joint guidelines, not fragmented competition.
GPs have faithfully served the Malaysian public for decades, often as the first and most consistent contact for health care.
Yet, the growing imbalance in regulation between GP clinics and pharmacies risks eroding both morale and fairness within the system.
It is time for policymakers to recognise that equal responsibility must come with equal regulation.
A level playing field will not only protect patients but also preserve trust, professionalism, and harmony within Malaysia’s health care ecosystem.
This statement was issued by Dr Devadas Pathiyil Ramankutty, president of the Association of Private Practitioners Sabah (APPS).
- This is the personal opinion of the writer or publication and does not necessarily represent the views of CodeBlue.
